VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 89 filers reported holding VERONA PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,669,163 | +197.4% | 1,636,822 | +285.5% | 0.02% | +183.3% |
Q2 2023 | $8,968,746 | +100.1% | 424,556 | +90.4% | 0.01% | +100.0% |
Q1 2023 | $4,482,883 | -68.1% | 223,029 | -58.6% | 0.00% | -70.0% |
Q4 2022 | $14,058,347 | +357.6% | 538,634 | -10.2% | 0.01% | +400.0% |
Q3 2022 | $3,072,069 | – | 600,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 2,457,499 | $16,932,000 | 5.79% |
Aisling Capital Management LP | 1,332,485 | $9,327,000 | 1.60% |
Ghost Tree Capital, LLC | 810,000 | $5,670,000 | 1.26% |
Vivo Capital, LLC | 3,048,507 | $21,340,000 | 0.95% |
NEA Management Company, LLC | 5,108,563 | $35,760,000 | 0.94% |
Novo Holdings A/S | 2,608,755 | $18,261,000 | 0.78% |
Samsara BioCapital, LLC | 1,111,112 | $7,778,000 | 0.78% |
SPHERA FUNDS MANAGEMENT LTD. | 1,033,603 | $7,235,000 | 0.64% |
RA Capital Management | 5,100,000 | $31,824,000 | 0.44% |
Orbimed Advisors | 5,694,841 | $39,864,000 | 0.35% |